Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
8.66B | 9.08B | 9.40B | 9.64B | 10.15B | 10.65B | Gross Profit |
3.08B | 3.26B | 3.06B | 3.21B | 3.63B | 3.47B | EBIT |
323.66M | 547.58M | 418.90M | 467.68M | 952.04M | 704.86M | EBITDA |
686.66M | 1.01B | 703.00M | 1.02B | 1.41B | 994.66M | Net Income Common Stockholders |
433.67M | 450.65M | 323.84M | 457.08M | 615.47M | 444.21M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
5.64B | 5.45B | 5.34B | 5.53B | 6.11B | 7.48B | Total Assets |
17.76B | 17.32B | 18.63B | 18.83B | 18.64B | 18.83B | Total Debt |
1.61B | 1.42B | 1.92B | 2.03B | 2.25B | 2.58B | Net Debt |
-4.03B | -4.02B | -3.42B | -3.50B | -3.86B | -4.90B | Total Liabilities |
4.09B | 3.65B | 4.69B | 5.11B | 5.22B | 6.02B | Stockholders Equity |
12.54B | 12.56B | 12.64B | 12.40B | 12.04B | 11.54B |
Cash Flow | Free Cash Flow | ||||
0.00 | 169.94M | 49.76M | -337.95M | -1.02B | -666.10M | Operating Cash Flow |
0.00 | 340.99M | 530.27M | 279.42M | -594.86M | -411.82M | Investing Cash Flow |
0.00 | 1.28B | -44.99M | -700.91M | -832.14M | -237.84M | Financing Cash Flow |
0.00 | -735.83M | -349.43M | -540.72M | -580.87M | 1.04B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
84 Outperform | ¥6.73B | 3.93 | 1.67% | 6.18% | 206.74% | ||
79 Outperform | ¥64.45B | 10.48 | 4.17% | 8.31% | 21.11% | ||
78 Outperform | ¥13.53B | 9.46 | 7.11% | 9.08% | 53.84% | ||
76 Outperform | ¥14.74B | 13.65 | 4.45% | 0.16% | 5.68% | ||
71 Outperform | ¥9.88B | 21.93 | 2.27% | -3.36% | 39.15% | ||
68 Neutral | ¥77.38B | 12.51 | 3.53% | 4.55% | 4.94% | ||
62 Neutral | $11.93B | 10.60 | -7.51% | 3.00% | 7.40% | -8.09% |